Is HUMAN PAPILLOMA VIRUS VACCINE (RDNA) registered in Uganda?

HUMAN PAPILLOMA VIRUS VACCINE (RDNA) is recorded with registration status “Registered” in Uganda, registration number NDA/MAL/HDP/6810, based on NDA data.

Who manufactures HUMAN PAPILLOMA VIRUS VACCINE (RDNA)?

HUMAN PAPILLOMA VIRUS VACCINE (RDNA) is manufactured by Glaxosmithkline Boilogicals, S.a Rue De I'institut 89 B-1330 Rixensart.

Registered Uganda · NDA

HUMAN PAPILLOMA VIRUS VACCINE (RDNA)

NDA/MAL/HDP/6810 PARENTERAL ORDINARY PRE-FILLED SYRINGES TYPE 16 L1 PROTEIN + TYPE 18 L1 PROTEIN + 3-0-DESACYL-4'MONOPHOSPHORYL LIPID A(MPL)

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/6810

Registration date

01/07/2007

Expiry date

Status

Registered

Active ingredient

Dosage form

PARENTERAL ORDINARY PRE-FILLED SYRINGES

Strength

TYPE 16 L1 PROTEIN + TYPE 18 L1 PROTEIN + 3-0-DESACYL-4'MONOPHOSPHORYL LIPID A(MPL)

Pack size

1.0X10.0X0.5 ML VIAL,1.0X0.5 ML PRE- FILLED SYRINGE (1 DOSE) + A 25 GAUGE NEEDLE

Therapeutic class

Manufacturer / MAH

Glaxosmithkline Boilogicals, S.a Rue De I'institut 89 B-1330 Rixensart

Applicant / LTR

GSK BIOLOGICALS SA

Country of origin

BELGIUM

Manufacturer location

Rue de l'Institut 89, 1330 Rixensart, Belgium

Source: National Drug Authority · fetched 2026-04-21 17:37:08 · updated 2026-09-12 04:00:21

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.